Global health agencies announced Wednesday that generic versions of a groundbreaking injectable drug to prevent HIV will be made available from 2027 at around $40 a year in more than 100 low and middle-income countries26. September 2025
Health Heartflow receives FDA clearance for updated plaque analysis platformHealthradar26. September 2025 Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:…
News Heartflow Receives FDA Clearance for Next-Gen AI Plaque Analysis, Expands Cigna CoverageHealthradar23. September 2025 What You Should Know: – Heartflow, a leader in AI technology for coronary artery disease (CAD), has received U.S. Food…
News UnitedHealthcare to Cover Elucid’s PlaqueIQ CTA Plaque Analysis Starting 10/1Healthradar13. August 2025 What You Should Know: – United Healthcare has updated its cardiac imaging guidelines to align with recommendations from radiology benefit…
